Evoq Remedies Limited has announced the outcome of its Extra-Ordinary General Meeting held through video conferencing. Key decisions include approval to increase the authorized share capital, amendments to the Memorandum of Association including the object clause, and approval for the issue and allotment of equity shares on a preferential basis. The meeting also approved the appointment of Ms. Pushpa Joshi as a Non-Executive Independent Director. Votes cast during the meeting will be combined with prior remote e-voting results, which will be announced shortly. These actions aim to support the company’s capital structure and board strengthening efforts.